GM24343
LCL from B-Lymphocyte
Description:
BETHLEM MYOPATHY
COLLAGEN, TYPE VI, ALPHA-3; COL6A3
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific PIGI Consented Sample |
Class |
Congenital Muscle Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
GERMAN/SLOVAK
|
Family Member
|
1
|
Family History
|
Y
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
COL6A3 |
Chromosomal Location |
2q37 |
Allelic Variant 1 |
D563G; BETHLEM MYOPATHY |
Identified Mutation |
ASP563GLY |
Remarks |
Clinically affected; symptom onset at age range 6-10 years; current maximal motor function: walk without assistance greater than 10 steps; can hold head up, turn in bed, sit, stand, walk indoors, and climb stairs with a handrail, all without assistance; motor functions achieved but not currently maintained: walking outdoors without assistance and running; breathing support required at night only; donor subject is heterozygous for an A>G transition at nucleotide 1688 in exon 5 of the COL6A3 gene resulting in the substitution of glycine for aspartic acid at codon 563 [Asp563Gly (D563G)]; positive family history: mother, daughter (GM23324), sister and two nieces are also affected. |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|